Distinct cutoff values of adalimumab trough levels are associated with different therapeutic outcomes in patients with inflammatory bowel disease

Sang Hyoung Park, Badr Al-Bawardy, Satimai Aniwan, Sunanda V. Kane, Nayantara Coelho-Prabhu, Konstantinos A. Papadakis, John B. Kisiel, David H. Bruining, William A. Faubion, Laura E. Raffals, Darrell S. Pardi, William J. Tremaine, Michael C. Stephens, Jeanne Tung, Sahil Khanna, Maria Alice V. Willrich, Edward V. Loftus

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Distinct cutoff values of adalimumab trough levels are associated with different therapeutic outcomes in patients with inflammatory bowel disease'. Together they form a unique fingerprint.

Medicine & Life Sciences